NCT05721092

Brief Summary

Asia has the highest burden with the largest contribution of pneumonia burden from India. Pneumonia is also observed as 5th leading cause of deaths in India. People with diabetes with uncontrolled glucose are significantly at higher risk of development of pneumonia. Even though, pneumonia is a vaccine-preventable disease, hospitalization for pneumonia of patients with diabetes are rising. Very limited literature is available on the knowledge and practice of pneumonia vaccination among diabetologists and the rate of pneumonia vaccination received by the patients with diabetes. Hence this study aims to assess their knowledge on the same. In addition, this study also aims to identify the real barriers and facilitators of pneumococcal vaccination among diabetologists in India. A cross-sectional study will be conducted among 25diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 9, 2023

Completed
11 days until next milestone

Study Start

First participant enrolled

February 20, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2024

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

1.1 years

First QC Date

January 31, 2023

Last Update Submit

March 22, 2024

Conditions

Pneumococcal Vaccine

Outcome Measures

Primary Outcomes (1)

  • To identify the facilitators and barriers of pneumococcal vaccination among diabetologists in India.

    6 months

Secondary Outcomes (3)

  • To assess the knowledge, attitude and practices of pneumococcal vaccination among select diabetologists across India.

    6 months

  • To examine the association of knowledge and practice of vaccination among diabetologists

    6 months

  • To assess the change in the knowledge of pneumococcal vaccination post educational intervention

    6 months

Interventions

Pre and Post Education on practice of pneumococcal vaccinationOTHER

A cross-sectional study will be conducted among 25 diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Diabetologists aged 25 to 65, practicing in India

You may qualify if:

  • Diabetologists willing to participate in the study

You may not qualify if:

  • Unwillingness to give consent for participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M V Hospital for Diabetes [P] Limited

Chennai, Tamil Nadu, 600013, India

Location

MeSH Terms

Interventions

Lead

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsMetals

Study Officials

  • Vijay Viswanathan

    M V Hospital for Diabetes [P] Limited

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Managing Director

Study Record Dates

First Submitted

January 31, 2023

First Posted

February 9, 2023

Study Start

February 20, 2023

Primary Completion

March 22, 2024

Study Completion

March 22, 2024

Last Updated

March 25, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations

IN(1)